Benitec Biopharma Statistics
Total Valuation
BNTC has a market cap or net worth of $406.15 million. The enterprise value is $306.98 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BNTC has 25.60 million shares outstanding. The number of shares has increased by 46.71% in one year.
Current Share Class | 25.60M |
Shares Outstanding | 25.60M |
Shares Change (YoY) | +46.71% |
Shares Change (QoQ) | +74.85% |
Owned by Insiders (%) | 5.92% |
Owned by Institutions (%) | 41.47% |
Float | 12.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.97 |
P/TBV Ratio | 4.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.80, with a Debt / Equity ratio of 0.01.
Current Ratio | 14.80 |
Quick Ratio | 14.74 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.57% and return on invested capital (ROIC) is -34.13%.
Return on Equity (ROE) | -48.57% |
Return on Assets (ROA) | -31.34% |
Return on Invested Capital (ROIC) | -34.13% |
Return on Capital Employed (ROCE) | -30.69% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.66M |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +116.44% in the last 52 weeks. The beta is 0.44, so BNTC's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | +116.44% |
50-Day Moving Average | 13.75 |
200-Day Moving Average | 11.60 |
Relative Strength Index (RSI) | 63.84 |
Average Volume (20 Days) | 43,849 |
Short Selling Information
Short Interest | 439,202 |
Short Previous Month | 354,058 |
Short % of Shares Out | 1.72% |
Short % of Float | 3.59% |
Short Ratio (days to cover) | 12.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -30.14M |
Pretax Income | -21.69M |
Net Income | -26.49M |
EBITDA | -30.06M |
EBIT | -30.14M |
Earnings Per Share (EPS) | -$1.47 |
Full Income Statement Balance Sheet
The company has $103.58 million in cash and $959,000 in debt, giving a net cash position of $102.62 million or $4.01 per share.
Cash & Cash Equivalents | 103.58M |
Total Debt | 959,000 |
Net Cash | 102.62M |
Net Cash Per Share | $4.01 |
Equity (Book Value) | 97.57M |
Book Value Per Share | 3.82 |
Working Capital | 96.98M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.67 million and capital expenditures -$18,000, giving a free cash flow of -$18.69 million.
Operating Cash Flow | -18.67M |
Capital Expenditures | -18,000 |
Free Cash Flow | -18.69M |
FCF Per Share | -$0.73 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BNTC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -46.71% |
Shareholder Yield | -46.71% |
Earnings Yield | -6.47% |
FCF Yield | -4.56% |
Dividend Details Analyst Forecast
The average price target for BNTC is $24.71, which is 55.75% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.71 |
Price Target Difference | 55.75% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 26, 2023. It was a reverse split with a ratio of 0.0588235:1.
Last Split Date | Jul 26, 2023 |
Split Type | Reverse |
Split Ratio | 0.0588235:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |